Millions of people, particularly in African countries, have lost access to drug treatments, prevention and testing putting the idea of ending the Aids pandemic by 2030 out of reach ...

Merck , known as MSD outside of the United States and Canada, today announced topline results from the pivotal double-blind Phase 3 trial of the investigational, once-daily, oral, two-drug, ...

To put this spike into perspective, the rural city of around 32,000 people has now recorded more HIV cases in two years than ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...

CABELL COUNTY, W.Va. (WSAZ) - The Cabell-Huntington Health Department is putting an end to their needle exchange program. The ...

Premier Wab Kinew defended his government’s plan to open a supervised consumption site in downtown Winnipeg, saying a public ...

It turned out that in a suicide attempt, she had ingested leaves of the English yew tree, which contains cardiotoxic taxane ...

Gilead Sciences shows strong growth potential with raised guidance, patent protection, and undervaluation. Learn more about GILD stock here.

Among adults with controlled HIV, switching from DTG/3TC to BIC/FTC/TAF did not significantly alter systemic inflammation and metabolic parameters.

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

An uncounted number of extra people have died from AIDS and 2.5 million have lost access to medicine to block the spread of ...